Confusion: Stocks tank then rebound after conflicting reports on efficacy of Gilead virus treatment drug "remdesivir"
By CNBC / April 24, 2020 / marketsanity.com / Article Link
"As such, the study results are inconclusive, though trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease."